Skip to content
Clinical Trials for Alzheimer's Disease

Los Angeles, California

Alzheimer's disease clinical trials in Los Angeles, CA

16 Alzheimer's disease studies are recruiting participants at sites in Los Angeles as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Los Angeles at a glance

  • 16 studies are recruiting at a site in Los Angeles.
  • By phase: Phase 1 (1), Phase 1/2 (1), Phase 2 (1), Phase 3 (7), No phase (6). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (9), university, hospital or other (7).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Los Angeles

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Inglewood Clinicals
    Registry record
    NCT07177352 · updated
  2. Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC)
    Registry record
    NCT05980949 · updated
  3. A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

    • Phase 3
    • Ages 55 to 80
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Inglewood Clinicals
    Registry record
    NCT07717411 · updated
  4. A Study of LY3439539 in Participants With Alzheimer's Disease

    • Phase 1
    • Ages 50 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Inglewood Clinical
    Registry record
    NCT07598370 · updated
  5. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    USC - The Memory and Aging Center (MAC) - Alzheimer Disease Research Center (ADRC)
    Registry record
    NCT06585787 · updated
  6. [18F]PI-2620 Phase 3 Histopathological Study

    • Phase 3
    • Ages 50 and older
    • All sexes
    Sponsor
    Lantheus Biosciences Ltd.
    Study site
    UC Los Angeles
    Registry record
    NCT05641688 · updated
  7. A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

    • Phase 2
    • Ages 50 to 85
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Inglewood Clinical ( Site 1062)
    Registry record
    NCT07033494 · updated
  8. Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study

    • No phase
    • Ages 55 to 89
    • All sexes
    Sponsor
    Cedars-Sinai Medical Center
    Registry record
    NCT07224607 · updated
  9. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Inglewood Clinical
    Registry record
    NCT06976203 · updated
  10. Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)

    • Phase 1/2
    • Ages 55 to 100
    • All sexes
    Sponsor
    University of California, Los Angeles
    Study site
    UCLA TMS Clinical and Research Service
    Registry record
    NCT06597942 · updated
  11. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Study site
    University of California, Los Angeles (UCLA) - David Geffen School of Medicine
    Registry record
    NCT06563895 · updated
  12. A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, Los Angeles
    Study sites
    University of California Los Angeles · Veterans Affairs Greater Los Angeles Healthcare System
    Registry record
    NCT05452031 · updated
  13. Polyphenols and Cognitive Decline

    • No phase
    • Ages 50 and older
    • All sexes
    Sponsor
    University of California, Los Angeles
    Study site
    University of California, Los Angeles
    Registry record
    NCT06507254 · updated
  14. The INSPIRE -Faith Study: Intervention Strategies for Preserving Intellectual Resilience and Engagement

    • No phase
    • Ages 55 to 85
    • All sexes
    Sponsor
    Healthy Minds Initiative
    Study site
    Crenshaw Christian Center
    Registry record
    NCT06741865 · updated
  15. Cardiac-Control Affecting Learning Through Mindfulness (CALM)

    • No phase
    • Ages 50 to 70
    • All sexes
    Sponsor
    University of Southern California
    Study site
    University of Southern California
    Registry record
    NCT06410157 · updated
  16. Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Southern California
    Study site
    University of Southern California
    Registry record
    NCT06418971 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Los Angeles, CA on ClinicalTrials.gov.

Ask about studies near Los Angeles

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call